E-cigarette: Reexamining its Effectiveness and Regulation in Europe

Aug.14.2023
E-cigarette: Reexamining its Effectiveness and Regulation in Europe
E-cigarette sales are increasing, prompting calls for stricter regulations to curb the rising trend among teenagers in Europe.

The e-cigarette, once hailed as a smoking cessation tool, may warrant reconsideration as tobacco companies are now advocating for stricter regulations on its usage.


In recent years, the phenomenon of teenagers using e-cigarettes has been spreading across Europe.


Since 2013, the number of teenagers aged 11 to 17 in the UK who have used e-cigarettes has quadrupled. In France, over half of teenagers aged 17 have tried e-cigarettes. In Italy, the proportion of teenagers aged 11 to 17 who have used e-cigarettes in the past month has doubled since 2014, and there has also been a noticeable increase in Latvia and Romania.


While e-cigarettes are widely believed to assist adult smokers in quitting, government officials, doctors, public health experts, and the general public are now sounding the alarm over the increasing use of these products among teenagers. Even the industry itself is calling for stronger regulation.


James Murphy, director of research and science at British American Tobacco (BAT), has stated that the company is willing to take measures to reduce the appeal and accessibility of e-cigarettes to young people.


He stated:


I believe that if we establish these protective measures in our surroundings, it will further redirect the attention of adults who are interested in making a change, while making it less appealing for teenagers whom we do not want to be exposed to these products.


His comments echo those of his boss, Tadeu Marroco, the CEO of British American Tobacco, who earlier this month stated the need for "better regulations" to address the issue of youth vaping.


Since e-cigarettes first entered the market, there has been a significant shift with the emergence of small disposable e-cigarettes in soft colors and cotton candy-like flavors. These e-cigarettes are now easily obtainable from unscrupulous sellers across Europe.


A new reality has prompted people to question whether lawmakers were completely mistaken when they formulated regulations for e-cigarettes a decade ago, and if it is now necessary to amend these rules.


The intense showdown among the legislators, coupled with rumors, threats, and fierce lobbying.


On October 8, 2013, at the European Parliament in Strasbourg, tensions ran high as Linda McAvan, the chief negotiator for the Tobacco Products Directive, called for a "wise and calm" discussion, urging to avoid the "distortions" witnessed in recent weeks.


The topic of the meeting was the proposal by the European Commission to classify the majority of e-cigarettes as medicinal products, which would require them to go through a pharmaceutical authorization process. EU member states have mostly reached a consensus on this issue, but European Parliament members have not yet made a decision.


Lobbyists and avid e-cigarette users are becoming increasingly restless, fueling rumors that Brussels is planning to ban e-cigarettes. The members of parliament have been bombarded with intense lobbying tactics, with some describing the situation as unprecedented within the usual scope of parliamentary proceedings.


McCarthy, a member of the Labour Party in the UK, is also a member of the Social and Democratic Progressive Party. She stated that although the documents primarily address traditional cigarettes, the issue of e-cigarettes has quickly become a major topic of discussion.


It quickly turned into a highly aggressive lobbying campaign," the former Member of the European Parliament told Politico magazine. The CEO of an e-cigarette company was relentless, she said, leaving messages on her phone and sending emails to her, referring to McCawen as his "archenemy." She and her team had considered filing a police report.


In the end, lobbying groups and enthusiastic e-cigarette users successfully persuaded lawmakers that e-cigarettes require lenient regulatory measures.


They are nearly zealous advocates for e-cigarettes," liberal member of parliament Rebecca Taylor remarked to The New York Times, describing herself as "one of several European Parliament members who have been urged by former smokers to embrace the use of e-cigarettes.


Taylor and other members of liberal, European conservative, and European People's Party groups have proposed amendments that would eliminate the requirement for e-cigarettes to undergo medicinal authorization, only requiring authorization if they are claimed to be smoking cessation devices.


The amendment ultimately passed.


Dr. Jørgen Vestbo, a renowned clinical physician and honorary professor of respiratory medicine at the University Hospital of South Manchester in the United Kingdom, has been persistently critical of e-cigarettes. He firmly believes that transforming e-cigarettes into medical products could help prevent numerous issues that have already arisen.


Tidying up the chaos


The focus has shifted from health to attracting young people in the tobacco industry, and European regulations have generally worked well. Murphy describes it as a "fairly pragmatic regulatory framework" that has led many people to switch from smoking to e-cigarettes. He says,


This is why some of the lowest smoking rates in the world have emerged.


However, he also suggested that perhaps the rules should be adjusted to reduce the interest of teenagers in using e-cigarettes.


Murphy stated that BAT is willing to restrict the flavors of e-cigarettes to three categories, such as tobacco, mint, and fruit, while excluding candy and other novelty flavors like alcohol (which requires little effort for BAT as the company currently only offers these three flavor categories).


I believe that standards can be established regarding packaging and formatting, for example, 'these are the acceptable formats' and 'this is the permitted packaging style'.


The transformation has already begun.


The National Anti-Smoking Committee in France has proposed a ban on all flavors, while the then Health Minister, François Braun, expressed support for the prohibition of disposable e-cigarettes in May.


In Germany, the Bavarian government is pushing for a ban on disposable e-cigarettes across the European Union. The country's drug commissioner states that regulating the appearance and packaging of e-cigarettes will help reduce their usage among young people.


In the United Kingdom, the government is not only encouraging companies to seek drug licenses for their products, but it is also planning to introduce new taxes on e-cigarettes. Additionally, there are plans to offer introductory e-cigarette kits to smokers.


At the same time, the European Commission has retained the possibility of stricter e-cigarette regulation in its future revision of the Tobacco Products Directive, stating that further consideration should be given to the need for developing or clarifying regulations regarding the use of flavors and advertising promotions.


As Brussels starts considering the potential revision of regulations, lawmakers who supported the light-touch approach a decade ago now appear to be more open to regulation.


European People's Party MEP Peter Liese supported an amendment in 2013 to halt the categorization of medical products. He maintains an open stance towards implementing stricter regulations for e-cigarettes, including cracking down on the use of flavors.


He also pointed out that it is necessary to evaluate disposable e-cigarettes to determine whether they should continue to be allowed. He stated that the only reason these products exist is to attract those who are unwilling to purchase long-term use devices: "Of course, there is a hope for more children who want to quit smoking than smokers," he said.


Even e-cigarettes could potentially be included in prescriptions and could offer some help, as it would mean the product can be reimbursed, allowing individuals who truly need these products to access them at a lower price, according to Lisa.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Holdings said the U.S. Food and Drug Administration notified the company on June 23, 2026, that 30 PACHA vape SKUs with submitted PMTAs had been tentatively identified for inclusion on a planned public-facing FDA webpage. Under enforcement guidance issued by FDA in May, the webpage is intended to identify certain unauthorized products for which the agency generally does not intend to prioritize enforcement of premarket authorization requirements. Charlie’s disclosed the development alongside second-quarter revenue of $3.8 million, up 116% year over year.
Aug.25
Major U.S.  Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
Major U.S. Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
New York vape distributor Ecto World, which operates as Demand Vape, hired political consultant Roger Stone to lobby the Executive Office of the President on regulation of vaping and related products while facing state enforcement and multiple lawsuits. Public lobbying disclosures show that Ecto World paid at least $300,000 for the work through June 30, 2026. Separately, New York State announced in March that more than 28,500 pounds of vaping products tied to the company had been seized, while New York City and the state have pursued legal or enforcement actions. Public records do not show that the lobbying directly changed any specific regulatory or enforcement outcome.
Sep.08
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI nicotine pouch brand Nordic Spirit has entered a long-term partnership with Manchester’s Co-op Live, becoming the venue’s Official Nicotine Pouch Partner. The 23,500-capacity venue is the UK’s largest indoor live entertainment arena. Nordic Spirit will run in-venue activations for existing adult nicotine consumers and sell products at selected arena bars. The agreement was entered into before the relevant UK sponsorship restrictions were introduced, while the government intends to implement a comprehensive ban on advertising and sponsorship of vaping and nicotine products from June 1, 2027.
Sep.07